Anti-TB Drug for Tuberculosis Spondylitis

Neurologico Spinale Medico Chirurgico

View Publication Info
Field Value
Title Anti-TB Drug for Tuberculosis Spondylitis
Creator Ibrahim, Chandra Satria
Subject -
Description Tuberculosis spondylitis, or spinal tuberculosis, is a disease that occurs throughout the world. Conservative therapy that is given to patients with spinal tuberculosis actually gives good results, but in certain cases, it requires surgery and rehabilitation therapy. The incidence of tuberculous spondylitis varies worldwide and is usually associated with the quality of available public health service facilities as well as the social factors in the country. Currently, tuberculosis spondylitis is a major source of morbidity and mortality in underdeveloped countries, especially in Asia, where malnutrition and population still remains a major issue. The goals of therapy in tuberculosis spondylitis are eradication of infection or at least to prevent neurological deterioration, and prevention or correction of a deformity or neurological deficit. Administration of anti-tuberculosis drugs is a major therapeutic principle in all cases including spinal tuberculosis. Early administration of anti-tuberculous drugs can significantly reduce morbidity and mortality.
Publisher Indoscholar
Date 2018-08-07
Type info:eu-repo/semantics/article
Conference Abstract
Format application/pdf
Source Neurologico Spinale Medico Chirurgico; Supplementary Issue - Conference Abstracts; 18
Language eng

Contact Us

The PKP Index is an initiative of the Public Knowledge Project.

For PKP Publishing Services please use the PKP|PS contact form.

For support with PKP software we encourage users to consult our wiki for documentation and search our support forums.

For any other correspondence feel free to contact us using the PKP contact form.

Find Us


Copyright © 2015-2018 Simon Fraser University Library